Asia Pacific is a growing destination for conducting cost-effective clinical trials – between 2007 and 2018 trials in Asia constituted around 28.5% of all registered clinical trials globally – with patient recruitment increasing faster than both Europe and North America.
Download our second recording and listen to our experts, KoSung Lee, Andrew Castles and Rich Nelson, discussing why you should consider Australia as your Bridge to conducting successful Asia-Pacific Clinical Trials.
The key to any successful clinical trial is having a robust, responsive, and efficient supply chain process that enables consistent global supply. Australia is one of the most mature markets in the Asia-Pacific region for clinical trials, with the Australia drug sector investing more than AUD$1 billion annually into research and development and outsourcing services.
We provide a complete range of clinical trial services and we are committed to supporting clients at every stage of the clinical cycle, delivering best-in-class services efficiently and effectively.
Find out more about our Clinical Trial Services here